InvestorsHub Logo
Followers 22
Posts 1379
Boards Moderated 0
Alias Born 03/31/2017

Re: None

Saturday, 04/17/2021 6:59:23 PM

Saturday, April 17, 2021 6:59:23 PM

Post# of 403325
Loanranger...both you and SUN refer to SE (side effects) of Brilacidin in clinical trials...and SUN asserts they occur 50% of the time...but neither of you can not come up with "one" CITED IN FDA CLINICAL TRIALS for the 5 separate indications involving Brilacidin prior Clinical Trials.

So are you saying there were "SE" cited by FDA in some or all of the Clinical Trials (Phase I anc Phase II)? if so WHAT WERE THEY and if so Show how they occurred in over 50% of the candidate...

You can't, because Brilacidin SE were never asserted or noted by the FDA...There were NO SE asserted by FDA and the statement and inference is totally false!

Courtesy of JFM!

Leo Ehrilich Quote "If Brilacidin goes on to realize its promise as a broad spectrum antiviral, the potential benefits to patients and shareholders for this drug would likely be greater than I or anyone could have ever imagined.”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News